The radiation dose management market is set to reach US$ 1,349.5 Mn by 2027 from US$ 179.0 Mn in 2018 projecting rapid growth at a compounded annual growth rate (CAGR) of 25.8% during the forecast period from 2019 to 2027. The major drivers associated with radiation dose management market are rising prevalence of chronic ailment and stringent regulatory norm related to safety of radiation exposure in patients. Significant rise in diagnostic screening centers and rising public health awareness further propel the radiation dose management market.
"Capability to design robust radiation safety program and efficient collection of clinical data pertaining to patient disease screening increased the demand for software solutions"
In the present scenario the software solutions are spearheading the solution segment for radiation dose management market. Prominent features associated such as capability to design robust radiation safety program ensuring negligible side effects in patients exposed to radiation therapy increases the demand for software solutions. Efficient collection of clinical data pertaining to patient disease diagnosis further propels the market growth for software solutions. Services are keen to register steady growth in the near future owing to rising public health awareness resulting in early disease diagnosis and significant rise in diagnostic centers worldwide.
"Ease of operation, effective radiation dose monitoring and quick acquisition of precise images increases the popularity of computed tomography over other modalities"
Computed tomography is currently leading the modality segment for radiation dose management market. The inherent features associated with computed tomography are elimination of overlapping structures making the internal anatomy more apparent and visible. It guides the surgeons during critical surgical procedures, ease of operation, effective radiation dose monitoring and quick turnaround time are the key attributes which increase sits popularity over other modalities. Nuclear medicine scans have gained tremendous attention in the last decade owing to its capability in understanding the cellular metabolism in chronic disease, thorough investigation of tumor or infection and its spread in the body. It is a useful tool to validate whether the ongoing treatment protocol is effective or needs change.
"Stringent regulatory norms regarding patient safety receiving radiation therapy and rising prevalence of chronic disease drive the market growth in North America"
North America holds the largest market share of 36% in the regional segment for radiation dose management market. The chief parameters consolidating its market growth in North America are stringent norms imposed by healthcare agencies in patients receiving radiation therapy and rising prevalence of chronic disease resulting in early disease diagnosis. Favorable reimbursement scenario pertaining to utilization of radiation dose therapy further bolsters the market growth in the region. Europe represents 29.5% market share and is the second largest regional market owing to domicile of key players such as Bayer AG, Philips Healthcare, Sectra AB etc. promote the market performance of radiation dose management. Asia Pacific with a market share of 22% is keen to register outstanding growth over the forecast period on account of developing healthcare infrastructure and increasing medical tourism.
Medical device manufacturers specializing in radiation dose management solutions are Bayer AG, Fujifilm Holdings Corporation, Bracco Imaging S.P.A., GE Healthcare, Philips Healthcare, Medsquare, Novarad Corporation, Sectra AB, Pacshealth, LLC. and Qaelum N.V.
Historical & Forecast Period
This study report represents analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Radiation Dose Management market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2023-2033 |
| Base Year | 2024 |
| Forecast Period | 2025-2033 |
| Historical Year | 2023 |
| Unit | USD Million |
| Segmentation | |
Solution
| |
Modality
| |
|
Region Segment (2023-2033; US$ Million)
|
Key questions answered in this report
